Exportar registro bibliográfico


Treatment of bladder pain syndrome and interstitial cystitis: a systematic review (2016)

  • Authors:
  • Unidade: FMRP
  • DOI: 10.1007/s00192-015-2815-5
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso à fonteDOI
    Informações sobre o DOI: 10.1007/s00192-015-2815-5 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PAZIN, Carolina; MITIDIERI, Andréia Moreira de Souza; SILVA, Ana Paula Moreira; et al. Treatment of bladder pain syndrome and interstitial cystitis: a systematic review. International Urogynecology Journal, London, v. 27, p. 697-708, 2016. Disponível em: < http://dx.doi.org/10.1007/s00192-015-2815-5 > DOI: 10.1007/s00192-015-2815-5.
    • APA

      Pazin, C., Mitidieri, A. M. de S., Silva, A. P. M., Gurian, M. B. F., Poli Neto, O. B., & Rosa e Silva, J. C. (2016). Treatment of bladder pain syndrome and interstitial cystitis: a systematic review. International Urogynecology Journal, 27, 697-708. doi:10.1007/s00192-015-2815-5
    • NLM

      Pazin C, Mitidieri AM de S, Silva APM, Gurian MBF, Poli Neto OB, Rosa e Silva JC. Treatment of bladder pain syndrome and interstitial cystitis: a systematic review [Internet]. International Urogynecology Journal. 2016 ; 27 697-708.Available from: http://dx.doi.org/10.1007/s00192-015-2815-5
    • Vancouver

      Pazin C, Mitidieri AM de S, Silva APM, Gurian MBF, Poli Neto OB, Rosa e Silva JC. Treatment of bladder pain syndrome and interstitial cystitis: a systematic review [Internet]. International Urogynecology Journal. 2016 ; 27 697-708.Available from: http://dx.doi.org/10.1007/s00192-015-2815-5

    Referências citadas na obra
    Campbell F, Collett BJ (1994) Chronic pelvic pain. Br J Anaesth 73:571–573. doi: 10.1093/bja/73.5.571
    Grace V, Zondervan K (2006) Chronic pelvic pain in women in New Zealand: comparative well-being, comorbidity, and impact on work and other activities. Health Care Women Int 27:585–599. doi: 10.1080/07399330600803725
    Howard FM (2003) Chronic pelvic pain. Obstet Gynecol 101:594–611. doi: 10.1016/S0029-7844(02)02723-0
    Hanno P, Dmochiwisk R (2009) Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurol Urodyn 28:274–286. doi: 10.1002/nau.20687
    Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Wein A (2002) The standardization of terminology of lower urinary tract function: report from the standardization subcommittee of the International Continence Society. Neurourol Urodyn 187:116–126. doi: 10.1067/mob.2002.125704
    Coelho MF, Rebola J (2003) Cistite Intersticial: etiopatogenia e atitudes terapêuticas. Acta Urol Lisboa 20:19–24
    Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, Nyberg L, Clemens JQ (2011) Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol 186:540–544. doi: 10.1016/j.juro.2011.03.132
    Yoost JL, Hertweck SP, Loveless M (2012) Diagnosis and treatment of interstitial cystitis in adolescents. J Pediatr Adolesc Gynecol 25:162–171. doi: 10.1016/j.jpag.2011.03.011
    Theoharides C (2007) Treatment approaches for painful bladder syndrome/interstitial cystitis. Drugs 67:215–235. doi: 10.2165/00003495-200767020-00004
    Forrest JB, Moldwin R (2008) Diagnostic options for early identification and management of interstitial cystitis/painful bladder syndrome. Int J Clin Pract 62:1926–1934. doi: 10.1111/j.1742-1241.2008.01931.x
    Hanno P, Nordling J, van Ophoven A (2008) What is new in bladder pain syndrome/interstitial cystitis? Curr Opin Urol 18:353–358. doi: 10.1097/MOU.0b013e3282fcea88
    Seth A, Teichman JMH (2008) What's new in the diagnosis and management of painful bladder syndrome/interstitial cystitis? Curr Urol Rep 9:349–357. doi: 10.1007/s11934-008-0061-9
    Tirumuru S, Al-Kurdi D, Latthe P (2010) Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome/interstitial cystitis: a systematic review. Int Urogynecol J 21:1285–1300. doi: 10.1007/s00192-010-1162-9
    Matsuoka PK, Haddad JM, Pacetta AM, Baracat EC (2012) Intravesical treatment of painful bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J 23:1147–1153. doi: 10.1007/s00192-012-1686-2
    Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12. doi: 10.1016/0197-2456(95)00134-4
    Barbalias GA, Liatsikos EN, Athanasopoulos A, Nikiforids G (2000) Interstitial cystitis: bladder training with intravesical oxybutynin. J Urol 163:1818–1822. doi: 10.1016/S0022-5347(05)67551-9
    O’Reilly BA, Dwyer PL, Hawthorne G, Cleaver S, Thomas E, Rosamilia A, Fynes M (2004) Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis. J Urol 172:1880–1883. doi: 10.1097/01.ju.0000142846.47245.16
    Smith CP, Chancellor MB (2004) Emerging role of botulinum toxin in the management of voiding dysfunction. J Urol 171:2128–2137. doi: 10.1097/01.ju.0000127725.48479.89
    Messing EM, Walsh PC, Retik AB, Stamey TA, Vaughan ED (1992) Campbell’s urology. In: Jr (eds) Interstitial cystitis and related syndromes, 6th edn. Philadelphia, pp 982–1005
    Hanno PM, Wein AJ (1994) Interstitial cystitis, part II. Urol Clin 21:136–141
    Porru D, Leva F, Parmigiani A, Barletta D, Gardella B, Dacco MD, Nappi RE, Allegri M, Tinelli C, Bianchi CM, Spinillo A, Rovereto B (2012) Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. Int Urogynecol J 23:1193–1199. doi: 10.1007/s00192-011-1546-5
    Parsons CL, Lilly JD, Stein P (1991) Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145:732–735
    Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pflüger H (2005) Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis? Eur Urol 47:393–397. doi: 10.1016/j.eururo.2004.10.022
    Nickel JC, Hanno P, Kumar K, Thomas H (2012) Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of Intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome. Urology 79:1220–1224. doi: 10.1016/j.urology.2012.01.059
    Shao Y, Shen ZJ, Rui WB, Zhou WL (2010) Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. J Urol 75:547–550. doi: 10.1016/j.urology.2009.09.078
    Lv YS, Zhou HL, Mao HP, Gao R, Wang YD, Xue XY (2012) Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis. Int Urogynecol J 23:1715–1720. doi: 10.1007/s00192-012-1802-3
    Anderson VR, Perry CM (2006) Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis. Drugs 4:18–23
    Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR (1990) Pentosan polysulfate sodium for therapy of interstitial cystitis: a double-blind placebo-controlled clinical study. Urology 35:552–558
    La Rock DR, Sant GR (1997) Intravesical therapies for interstitial cystitis. In: Sant GR (ed) Interstitial cystitis. Lippincott-Raven, Philadelphia
    Bade JJ, Laseur M, Nieuwenburg A, Van der Weele LT, Mensink HJ (1997) A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br J Urol 79:168–171. doi: 10.1046/j.1464-410X.1997.03384.x
    Davis EL, El Khoudary SR, Talbott EO, Davis J, Regan LJ (2008) Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol 179:177–185. doi: 10.1016/j.juro.2007.08.170
    Zeidman EJ, Helfrick B, Pollard C, Thompson IM (1994) Bacillus Calmette-Guérin immunotherapy for refractory interstitial cystitis. Urology 43:121–124. doi: 10.1016/S0090-4295(94)80284-X
    Peters K, Diokno A, Steinert B, Yuhico M, Mitchell B, Krohta S, Gillette B, Gonzalez J (1997) The efficacy of intravesical tice strain bacillus Calmette-Guérin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial. J Urol 157:2090–2094. doi: 10.1016/S0022-5347(01)64682-2
    Buyse G, Waldeck K, Verpoorten C, Björk H, Casaer P, Andersson KE, Buyse G, Waldeck K, Verpoorten C, Björk H, Casaer P, Andersson KE (1998) Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol 160:811–823. doi: 10.1016/S0022-5347(01)62828-3
    Simunovic Z, Trobonjaca T, Trobonjaca Z (1998) Treatment of medial and lateral epicondylitis-tennis and golfer’s elbow-with low level laser therapy: a multicenter double blind, placebo-controlled clinical study on 324 patients. J Clin Laser Med Surg 16:145–151
    Apostolidis A, Popat R, Yiangou Y, Cockayne D, Ford AP, Davis JB, Dasgupta P, Fowler CJ, Anand P (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174:977–983. doi: 10.1097/01.ju.0000169481.42259.54
    Kuo HC (2005) Clinical effects of suburothelial injection of botulinum A toxin on patients with non-neurogenic detrusor overactivity refractory to anticholinergics. Urology 66:94–98. doi: 10.1016/j.urology.2005.02.002
    Manning J, Dwyer P, Rosamilia A, Colyvas K, Murray C, Fitzgerald E (2013) A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndrome. Int Urogynecol J 25:593–595. doi: 10.1007/s00192-013-2267-8
    Neheman A, Nativ O, Moskovitz B, Melamed Y, Stein A (2005) Hyperbaric oxygen therapy for radiation-induced haemorrhagic cystitis. BJU 96:107–109. doi: 10.1111/j.1464-410X.2005.05577.x
    Rosamilia A, Cann L, Dwyer P, Scurry J, Rogers P (1999) Bladder microvasculature in women with interstitial cystitis. J Urol 161:1865–1870. doi: 10.1016/S0022-5347(05)68830-1
    Irwin P, Galloway NT (1993) Impaired bladder perfusion in interstitial cystitis: a study of blood supply using laser Doppler flowmetry. J Urol 149:890–892
    Pontari MA, Hanno PM, Ruggieri MR (1999) Comparison of bladder blood flow in patients with and without interstitial cystitis. J Urol 86:711–715. doi: 10.1016/S0022-5347(05)68552-7
    Van Ophoven A, Rossbach G, Pajonk F, Hertle L (2006) Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham-controlled, double-blind trial. J Urol 175:1442–1446. doi: 10.1016/j.juro.2006.06.065
    Mannocci JF (1995) Disfunções sexuais: abordagem clínica e terapêutica, 3rd edn. Fundo Editorial BYK, São Paulo
    FitzGerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, Kotarinos R, Fraser L, Cosby A, Fortman C, Neville C, Badillo S, Odabachian L, Sanfield A, O’Dougherty B, Halle-Podell R, Cen L, Chuai S, Landis JR, Mickelberg K, Barrell T, Kusek JW, Nyberg LM (2009) Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol 182:570–580. doi: 10.1016/j.juro.2009.04.022
    Simons DG, Travell JG, Simons LS (1998) Myofascial pain and dysfunction: the trigger point manual, 2nd edn. Lippincott Williams & Wilkins, Philadelphia
    FitzGerald MP, Payne CK, Lukacz ES, Yang CC, Peters KM, Chai TC, Nickel JC, Hanno PM, Kreder KJ, Burks DA, Mayer R, Kotarinos R, Fortman C, Allen TM, Fraser L, Mason-Cover M, Furey C, Odabachian L, Sanfield A, Chu J, Huestis K, Tata GE, Dugan N, Sheth H, Bewyer K, Anaeme A, Newton K, Featherstone W, Halle-Podell R, Cen L, Landis JR, Propert KJ, Foster HE Jr, Kusek JW, Nyberg LM (2012) Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol 182:2113–2118. doi: 10.1016/j.juro.2012.01.123
    Russo J Jr, Lipman AG, Comstock TJ, Page BC, Stephen RL (1980) Lidocaine anaesthesia: comparison of iontophoresis, injection and swabbing. Am J Hosp Pharm 22:152–155
    Hicks RM, Ketterer B, Warren RC (1974) The ultrastructure and chemistry of the luminal plasma membrane of the mammalian urinary bladder: a structure with low permeability to water and ions. Philos Trans R Soc Lond B Biol Sci 268:23–38
    Rosamilia A, Dwyer PL, Gibson J (1997) Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 8:142–145
    Porru D, Campus G, Tudino D, Valdes E, Vespa A, Scarpa RM, Usai E (1997) Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 59:26–29. doi: 10.1159/000283012
    Cervigni M, Natale F, Nasta L, Padoa A, Voi RL, Porru D (2008) A combined intravesical therapy with hyaluronic acidand chondroitin for refractory painful bladder syndrome/interstitial cystitis. Int Urogynecol J 19:943–247. doi: 10.1007/s00192-008-0572-4
    Giberti C, Gallo F, Cortese P, Schenone M (2013) Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study. Ther Adv Urol 5:175–179. doi: 10.1177/1756287213490052
    Daha LK, Lazar D, Simak R, Pflüger H (2007) Is there a relation between urinary interleukin-6 levels and symptoms before and after intra-vesical glycosaminoglycan substitution therapy in patients with bladder pain syndrome/interstitial cystitis? Int Urogynecol J 18:1449–1452. doi: 10.1007/s00192-007-0354-4
    Aghamir SM, Mohseni MG, Arasteh S (2007) Intravesical bacillus Calmette-Guérin for treatment of refractory interstitial cystitis. J Urol 4:18–23
    Magni G (1991) The use of antidepressants in the treatment of chronic pain. Drugs 42:730–748. doi: 10.2165/00003495-199142050-00002
    Weselmann U (2001) Interstitial cystitis: a chronic visceral pain syndrome. Urology 57:32–39. doi: 10.1016/S0090-4295(01)01123-2
    Wammack R, Remzi M, Seitz C, Djavan B, Marberger M (2002) Efficacy of oral doxepin and piroxicam treatment for interstitial cystitis. Eur Urol 41:596–600. doi: 10.1016/S0302-2838(02)00174-4
    Shie JH, Liu HT, Wang YS, Kuo HC (2013) Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome. BJU Int 111:638–646. doi: 10.1111/j.1464-410X.2012.11466.x
    Lee CL, Kuo HC (2013) Intravesical botulinum toxin A injections do not benefit patients with ulcer type interstitial cystitis. Pain Physician 16:109–116
    Mandel SA, Amit T, Kalfon L, Reznichenko L, Weinreb O, Youdim MB (2008) Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). J Alzheimers Dis 15:211–222
    Sant GR, Theoharides TC (1994) The role of the mast cell ininterstitial cystitis. Urol Clin North Am 21:41–53
    Liu M, Xu YF, Feng Y, Yang FQ, Luo J, Zhai W, Che JP, Wang GC, Zheng JH (2013) Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors. J Surg Res 183:397–404. doi: 10.1016/j.jss.2012.11.041
    Abehsira-Amar O, Gibert M, Joliy M, Thèze J, Jankovic DL (1992) IL-4 plays a dominant role in the differential development of TH0 into TH1 and TH2 cells. J Immunol 148:3820–3829
    Tsukagoshi H, Nagashima M, Horie T, Oyama T, Yoshii A, Sato T, Iizuka K, Dobashi K, Mori M (1998) Kimura’s disease associated with bronchial asthma presenting eosinophilia and hyperimmunoglobulinemia E which were attenuated by suplatast tosilate (IPD-1151T). Intern Med 37:1064–1067. doi: 10.2169/internalmedicine.37.1064
    Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N (2000) Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral Ipd-1151t. J Urol 164:1917–1920. doi: 10.1016/S0022-5347(05)66917-0
    Thon WF, Baskin LS, Jonas U, Tanagho EA, Schimidt RA (1991) Neuromodulation of voiding dysfunction and pelvic pain. World J Urol 9:138–141. doi: 10.1007/BF00202508
    Bosch JL, Groen J (1995) Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability: results of chronic electrical stimulation using an implantable neural prosthesis. Clin Urol 154:504–507. doi: 10.1016/S0022-5347(01)67086-1
    Maher CF, Carey MP, Dwyer PL, Schluter PL (2001) Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J Urol 165:884–886. doi: 10.1016/S0022-5347(05)66551-2
    Weiss JM (2001) Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol 166:2226–2231. doi: 10.1016/S0022-5347(05)65539-5
    Oyama IA, Rejba A, Lukban JC, Fletcher E, Kellogg-Spadt S, Holzberg AS, Whitmore KE (2004) Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology 6:862–865. doi: 10.1016/j.urology.2004.06.065

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2021